
Mira Pharmaceuticals
(NASDAQ) MIRA
Mira Pharmaceuticals Financials at a Glance
Market Cap
$43.13M
Revenue (TTM)
$0.00
Net Income (TTM)
$28.42M
EPS (TTM)
$-1.52
P/E Ratio
-0.68
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.00
Volume
109,335
Open
$1.05
Price
$1.00
Volume
109,335
Open
$1.05
Previous Close
$1.03
Daily Range
$1.00 - $1.06
52-Week Range
$0.73 - $2.45
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.00
Volume
109,335
Open
$1.05
Previous Close
$1.03
Daily Range
$1.00 - $1.06
52-Week Range
$0.73 - $2.45
MIRA News
MIRA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Mira Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
5
CEO
Erez Aminov
Website
mirapharmaceuticals.comHeadquarters
Baltimore, MD 21205, US
MIRA Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-511%
Return on Capital
-94%
Return on Assets
-4%
Earnings Yield
-1.47%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$43.13M
Shares Outstanding
41.88M
Volume
109.33K
Short Interest
0.00%
Avg. Volume
155.17K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$8.02M
EBITDA
$8.02M
Operating Cash Flow
$5.56M
Capital Expenditure
$4.00
Free Cash Flow
$5.56M
Cash & ST Invst.
$2.83M
Total Debt
$0.00
Mira Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$43.13M
N/A
Market Cap/Employee
$21.57M
N/A
Employees
2
N/A
Net Income
$22.69M
-1010.4%
EBITDA
$1.14M
N/A
Quarterly Fundamentals
Net Cash
$2.64M
-36.3%
Accounts Receivable
$35.44K
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-3.72%
N/A
Return on Invested Capital
-94.13%
N/A
Free Cash Flow
$1.10M
+40.5%
Operating Cash Flow
$1.10M
+40.5%